Main menu

Skip to primary content
Skip to secondary content
  • 2011 Annual Review
  • CEO Message
    • Highlights
  • Our Company
    • The Right Strategy
    • Strong Management Team
    • Culture of Excellence
    • Global Leader in MS
    • Manufacturing
    • Corporate Citizenship
  • Our Products
    • Tysabri
    • Avonex
    • Fampyra
    • Rituxan
  • Our Science
    • Multiple Sclerosis
    • Neurodegenerative Disease
    • Immunology
    • Hemophilia
    • Product Pipeline
  • Financials
  • Downloads
  • Corporate Information
ms-leader
  • Biogen Idec
  • 2011 Annual Review
  • Our Company
  • Global Leader in MS

Global Leader in MS

No one is doing more for patients living with MS. Biogen Idec is the global leader in MS with three treatments, TYSABRI, AVONEX and FAMPYRA. Motivated by an unwavering commitment to our patients, we have developed the industry's most robust pipeline of MS therapies.

  • The Right Strategy
  • Strong Management Team
  • Culture of Excellence
  • Global Leader in MS
  • Manufacturing
  • Corporate Citizenship
© 2012 Biogen Idec
Safe Harbor for Forward Looking Statements
Designed by Mentus Annual Reports